Clinical Trials Directory

Trials / Completed

CompletedNCT05933616

Analysis of Volatile Organic Compounds in Patients With Type 1 Diabetes in Induced Hypoglycaemia With a Breath Analyser

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
10 (actual)
Sponsor
University of Bern · Academic / Other
Sex
All
Age
18 Years – 50 Years
Healthy volunteers
Not accepted

Summary

The breath analysis (BreathSpec® device) data of all participants that were included into the VAARA study (NCT05771090) will be analysed, this includes data from up to 40 breath samples from each of the 10 participants who underwent 2 insulin-induced hypoglycaemic episodes during two visits. The primary objective is to find a possible association between volatile organic compounds (VOCs) measured by the BreathSpec® device and blood glucose. For this we will use descriptive statistics, correlation coefficients, as well as a Principal Component Analysis and a partial least squares discriminant analysis. Furthermore, the time lag between hypoglycaemia onset and change in VOCs will be quantified.

Conditions

Interventions

TypeNameDescription
DEVICEDevice: Sokru deviceDifferent induced glycaemic states in people living with diabetes (PwD).

Timeline

Start date
2023-04-20
Primary completion
2023-06-16
Completion
2024-07-31
First posted
2023-07-06
Last updated
2024-08-16

Locations

1 site across 1 country: Switzerland

Source: ClinicalTrials.gov record NCT05933616. Inclusion in this directory is not an endorsement.